Masayuki Saijo

The First Identification and Retrospective Study of Severe Fever With Thrombocytopenia Syndrome in Japan

Toru Takahashi, Ken Maeda, Tadaki Suzuki et al. · The Journal of Infectious Diseases · 2013 · 909 citations · Full text

A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19

Yohei Doi, Masaya Hibino, Ryota Hase et al. · Antimicrobial Agents and Chemotherapy · 2020 · 231 citations · Full text

Open-label Trial, Late Favipiravir Therapy, Clinical Infectious Disease +14

Severe Fever with Thrombocytopenia Syndrome, Japan, 2013–2017

Yusuke Kobayashi, Hirofumi Kato, Takuya Yamagishi et al. · Emerging infectious diseases · 2020 · 183 citations · Full text

Immunodeficiencies, Companion Animals, Thrombocytopenia Syndrome +18

Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment

Hirofumi Ohashi, Koichi Watashi, Wakana Saso et al. · iScience · 2021 · 180 citations · Full text

Phosphorylation of p38 MAPK and its downstream targets in SARS coronavirus-infected cells

Tetsuya Mizutani, Shuetsu Fukushi, Masayuki Saijo et al. · Biochemical and Biophysical Research Communications · 2004 · 174 citations

Downstream Targets, Signal Transduction, Signaling Pathway +9